PharVision Advisers’s AudioEye AEYE Stock Holding History

PharVision Advisers’s Portfolio AEYE Stock Details AEYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,696	Closed	-$178K	–	270
2024 Q4	$178K	Buy	+11,696	New	+$268K	0.15%	329

Other funds holding AEYE

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PharVision Advisers's AEYE Position: Q1 2025 in Review

PharVision Advisers sold out of AudioEye (AEYE) in Q1 2025, closing a stake of 11,696 shares — an estimated $178K sold.

PharVision Advisers first reported a position in AEYE in Q4 2024 and held it in 1 quarter. The position peaked at $178K in Q4 2024. 82 funds tracked by Wall St. Rank hold AEYE as of Q1 2025.

PharVision Advisers reported no remaining AudioEye position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 11,696 AudioEye shares in Q1 2025, an estimated $178K.
PharVision Advisers first reported a position in AudioEye in Q4 2024 and held it in 1 quarter.
PharVision Advisers's AudioEye position peaked at $178K in Q4 2024.
82 funds tracked by Wall St. Rank held AudioEye as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.